Pupek Małgorzata, Pawłowicz Robert, Lindner Karolina, Krzyżanowska-Gołąb Dorota, Lemańska-Perek Anna, Panaszek Bernard, Kątnik-Prastowska Iwona
Department of Chemistry and Immunochemistry, Wrocław Medical University, Bujwida 44a, 50-345 Wrocław, Poland.
Department and Clinic of Internal Diseases, Geriatrics and Allergology, Wrocław Medical University, Curie-Skłodowskiej 66, 50-367 Wrocław, Poland.
Exp Gerontol. 2016 May;77:19-28. doi: 10.1016/j.exger.2016.02.006. Epub 2016 Feb 13.
Multimorbidity is the co-occurrence of chronic diseases associated with low-grade chronic inflammation of connective tissue.
Frequency of occurrence and relative amounts of fibronectin (FN) complexes with fibrin (FN-fibrin) and FN monomer were analyzed in 130 plasma samples of 18 to 94-year-old multimorbid patients in relation to concentrations of FN and extra domain A (EDA)-FN, and C-reactive protein (CRP) as well as to age, number of coexisting chronic diseases and presence of specified diseases.
Immunoblotting revealed, besides FN dimer, the presence of FN monomer, and 750-, 1000-, and 1300-kDa FN-fibrin complexes in the multimorbid plasmas. The FN-fibrin complexes appeared more frequently and in higher relative amounts, but FN monomer less frequently and in a lower relative amount in the groups of elderly multimorbid patients, with a higher number of coexisting diseases and with dominance of cardiovascular diseases and osteoarthrosis, and with CRP concentration of 3-5mg/l. In contrast, the normal plasma contained only the FN-fibrin complex of 750 kDa in a lower relative amount, but with an increasing amount with normal aging. Moreover, FN concentration increased and EDA-FN decreased with the number of co-existing diseases and aging of patients, although both concentration values were lower than in the age-matched normal groups. FN concentration was the lowest in the exacerbation of a chronic disease and EDA-FN in the stable chronic disease groups.
The alterations in plasma FN molecular status were associated with micro-inflammation and micro-coagulation, as well as multimorbidity of subjects and their physiological aging.
多病共存是指与结缔组织低度慢性炎症相关的慢性疾病同时发生。
分析130份18至94岁多病共存患者的血浆样本中,纤连蛋白(FN)与纤维蛋白的复合物(FN-纤维蛋白)和FN单体的出现频率及相对含量,及其与FN、额外结构域A(EDA)-FN、C反应蛋白(CRP)的浓度,以及年龄、共存慢性疾病的数量和特定疾病的存在情况之间的关系。
免疫印迹显示,在多病共存患者的血浆中,除了FN二聚体,还存在FN单体以及750 kDa、1000 kDa和1300 kDa的FN-纤维蛋白复合物。在老年多病共存患者组、共存疾病数量较多且以心血管疾病和骨关节炎为主、CRP浓度为3 - 5mg/l的患者组中,FN-纤维蛋白复合物出现得更频繁且相对含量更高,而FN单体出现得更不频繁且相对含量更低。相比之下,正常血浆中仅含有相对含量较低的750 kDa的FN-纤维蛋白复合物,但随着正常衰老其含量会增加。此外,随着共存疾病数量的增加和患者年龄的增长,FN浓度升高而EDA-FN降低,尽管这两个浓度值均低于年龄匹配的正常组。在慢性疾病加重时FN浓度最低,在稳定的慢性疾病组中EDA-FN最低。
血浆FN分子状态的改变与微炎症、微凝血以及受试者的多病共存和生理衰老有关。